The treatment of coronary artery disease in the elderly

R J Backes1, B J Gersh

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.

Insights

Treating elderly patients with coronary artery disease (CAD) requires careful consideration due to limited data. Management strategies must adapt to aging changes and patient-specific factors for optimal outcomes in this growing population.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Public Health

Background:

  • Population demographics show an increasing prevalence of coronary artery disease (CAD) in elderly patients.
  • Limited data exists to guide the management of CAD in this specific demographic.
  • Aging changes affect renal function, hepatic metabolism, and increase comorbidities, complicating treatment decisions.

Purpose of the Study:

  • To review current approaches for managing coronary artery disease in the elderly.
  • To highlight the paucity of data and the need for evidence-based guidelines.
  • To discuss the implications of treatment decisions on quality of life and independence.

Main Methods:

  • Review of existing literature on coronary artery disease management in older adults.
  • Analysis of treatment outcomes for medical management, balloon dilatation, and coronary bypass grafting.
  • Consideration of factors such as renal function, hepatic metabolism, and comorbidities.

Main Results:

  • Mild coronary artery disease may be managed medically with adjustments for aging.
  • Balloon dilatation shows promise in selected high-risk patients, but its role in multivessel disease is under investigation.
  • Coronary bypass grafting improves survival in selected elderly patients, requiring careful selection and management.

Conclusions:

  • Management of coronary artery disease in the elderly necessitates individualized treatment plans.
  • Further research is needed to establish optimal strategies for this population.
  • Quality of life, functional independence, and cost are critical factors in decision-making for elderly CAD patients.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...